• Family of patient who died after orthopedic surgery wins $35M verdict against hospital
  • Orthopedic surgeon wins $20M verdict against Johnson & Johnson
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon's video hits 1 million views on TikTok
  • Spine surgeon killed in Oklahoma hospital shooting
  • Spine surgeon owes $17M to paralyzed patient
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • 23 spine device companies to watch in 2022
  • 4 spine technologies that promised more than they delivered
  • Orthopedic surgeon salary vs. average household income in each state
  • Orthopedic surgeon's health system exit steeped in controversy
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Orthopedic surgeon convicted of battery at hospital
  • Billionaire spine surgeon buys $23.9M mansion
  • UArizona neurosurgery chair dies after motorcycle collision
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • The spine tech surgeons say will explode in the next 5 years
  • Could Medtronic's spine business be the next medtech spinoff?
  • Ex-NFL player gets 5 years in prison for $2.9M healthcare fraud scheme
  • 41 'rising stars' in orthopedics
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon fined for operating on wrong knee
  • Lawsuits build against Aetna's spine surgery coverage
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Former spine surgeon owes $13M to 2 women over unnecessary procedures
  • Walmart's latest partnership pushes retailer into spine care
  • Texas spine surgeon's $11M verdict being appealed
  • 10 power players in orthopedics
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon allegedly exaggerated patient visits to defraud insurers
  • Top orthopedic hospital in every state: US News
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • How Medtronic is strengthening its spine business
  • $85M settlement reached in spinal cord stimulation lawsuits
  • Medtronic's next-gen predictive spine surgery model cleared
  • ZimVie's pediatric scoliosis device gets coverage by Anthem BCBS
  • Spinal fusion alternative device reaches FDA milestone
  • 6 things to know about the US spine device market

    6 things to know about the US spine device market

    Laura Dyrda -  

    The spinal implant market in the United States is expected to grow over the next 10 years, according to a Q2 Metrics report.

    Here are six things to know about the report:

     

    1. The U.S. spinal implant market is valued at around $5 billion this year and is expected to grow at a compound annual growth rate of 2.4 percent through 2024.

     

    2. Ten years from now, the U.S. spinal implant market is expected to reach $6.4 billion.

     

    3. The largest product segments feature largely commoditized products and lack product innovation. The largest product segments include:

     

    • Traditional anterior cervical plating
    • Posterior thoracolumbar pedicle screw fixation

     

    4. Pressure continues to mount to decrease cost of care. As a result, steady pricing decreases in the supply chain are expected in most spinal implant segments through 2024.

     

    5. Procedure shifts and product mix to premium-priced artificial discs, plate/cage hybrid devices with integrated screw fixation and minimally invasive alternatives will help offset declining unit prices.

     

    6. In the short term, the legacy artificial disc leaders will benefit from these shifts. Those leading companies include Medtronic Spinal and Biologics, DePuy Synthes Spine, LDR, NuVasive and Globus Medical.

     

    "We're seeing strong momentum in both hospital and physician reimbursement for artificial discs, which will help drive double-digit growth in this segment over the next ten years," said Q2 Metrics President Aaron Dickson. "And while the thoracoloumbar market has been hardest hit by pricing pressures, premium-priced LLIF and TLIF devices continue to cannibalize their ALIF and PLIF counterparts, helping drive a greater than $1 billion growth in this segment by 2024."

     

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Learning Opportunities

    Featured Webinars

    Featured Podcast

    Featured Whitepapers